Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$2.7B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.39B |
| 3 |
AbbVie
ABBV
|
+$1.95B |
| 4 |
Wells Fargo
WFC
|
+$1.03B |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$1.03B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Trip.com Group
TCOM
|
+$546M |
| 2 |
KRFT
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
|
+$274M |
| 3 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$273M |
| 4 |
Home Depot
HD
|
+$257M |
| 5 |
Progressive
PGR
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.23% |
| 2 | Healthcare | 10.87% |
| 3 | Financials | 9.03% |
| 4 | Technology | 8.57% |
| 5 | Consumer Discretionary | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5351
DELISTED
Sapiens International
SPNS
| $127K | ﹤0.01% |
12,280
-3,155
| -20% | -$28.6K |
2013 Q2
8 quarters
|
|
5352
DELISTED
Veritex Holdings
VBTX
| $127K | ﹤0.01% |
8,532
-3,190
| -27% | -$45.9K |
2014 Q4
2 quarters
|
|
|
NVCN
5353
DELISTED
Neovasc Inc.
NVCN
| $127K | ﹤0.01% |
+1
| New | +$193K |
2015 Q2
0 quarters
|
|
|
TRF
5354
DELISTED
TEMPLETON RUSSIA & EAST EURO FD
TRF
| $127K | ﹤0.01% |
12,642
-17,662
| -58% | -$194K |
2013 Q2
8 quarters
|
|
|
GUR
5355
DELISTED
SPDR S&P Emerging Europe ETF
GUR
| $127K | ﹤0.01% |
4,540
+58
| +1% | +$1.74K |
2013 Q2
8 quarters
|
|
|
FBRC
5356
DELISTED
FBR & Co. Common Stock
FBRC
| $127K | ﹤0.01% |
5,518
+1,123
| +26% | +$24.9K |
2013 Q2
8 quarters
|
|
5357
Gyrodyne
GYRO
$9.9M
| $126K | ﹤0.01% |
3,769
+99
| +3% | +$3.84K |
2013 Q2
8 quarters
|
|
|
OSHC
5358
DELISTED
Ocean Shore Holding Co.
OSHC
| $126K | ﹤0.01% |
8,527
+1,416
| +20% | +$21.4K |
2013 Q4
6 quarters
|
|
5359
DELISTED
LivePerson
LPSN
| $125K | ﹤0.01% |
849
-17,580
| -95% | -$2.56M |
2013 Q2
8 quarters
|
|
5360
OraSure Technologies
OSUR
$250M
| $125K | ﹤0.01% |
23,197
-504,659
| -96% | -$3.12M |
2013 Q2
8 quarters
|
|
|
CTIC
5361
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $125K | ﹤0.01% |
6,413
-634
| -9% | -$12.2K |
2013 Q2
8 quarters
|
|
|
NDRM
5362
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| $125K | ﹤0.01% |
8,095
+4,895
| +153% | +$68.9K |
2014 Q4
2 quarters
|
|
5363
Chegg
CHGG
$82.2M
| $124K | ﹤0.01% |
15,745
-15,743
| -50% | -$125K |
2013 Q4
6 quarters
|
|
5364
Protara Therapeutics
TARA
$144M
| $124K | ﹤0.01% |
174
+166
| +2,075% | +$103K |
2014 Q4
2 quarters
|
|
5365
DELISTED
Iteris, Inc.
ITI
| $124K | ﹤0.01% |
69,844
| – | – |
2013 Q2
8 quarters
|
|
5366
DELISTED
BioAmber Inc.
BIOA
| $124K | ﹤0.01% |
14,372
+2,900
| +25% | +$26.5K |
2013 Q4
6 quarters
|
|
|
ICA
5367
DELISTED
EMPRESAS ICA, S.A. DE C.V. ADS (EA REPTG 4 ORD PART CERT)
ICA
| $124K | ﹤0.01% |
39,700
-8,827
| -18% | -$30.8K |
2013 Q2
8 quarters
|
|
5368
Broadwind
BWEN
$80.2M
| $123K | ﹤0.01% |
29,001
-23,970
| -45% | -$100K |
2013 Q4
6 quarters
|
|
|
IMBI
5369
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
| $122K | ﹤0.01% |
4,516
-13,658
| -75% | -$650K |
2014 Q4
2 quarters
|
|
|
HIL
5370
DELISTED
Hill International, Inc. Common Stock
HIL
| $122K | ﹤0.01% |
23,001
-116,256
| -83% | -$554K |
2013 Q4
6 quarters
|
|
|
LTS
5371
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
| $122K | ﹤0.01% |
34,937
-1,658
| -5% | -$5.86K |
2013 Q2
8 quarters
|
|
5372
Ladder Capital
LADR
$1.16B
| $121K | ﹤0.01% |
8,731
-8,345
| -49% | -$120K |
2014 Q1
5 quarters
|
|
5373
Madrigal Pharmaceuticals
MDGL
$10.3B
| $121K | ﹤0.01% |
1,552
-3,929
| -72% | -$330K |
2013 Q2
8 quarters
|
|
5374
iShares MSCI Agriculture Producers ETF
VEGI
$169M
| $121K | ﹤0.01% |
4,490
+3
| +0.1% | +$82 |
2013 Q2
8 quarters
|
|
|
HMTV
5375
DELISTED
Hemisphere Media Group, Inc.
HMTV
| $121K | ﹤0.01% |
10,107
-1,060
| -9% | -$13.2K |
2013 Q4
6 quarters
|
|
Similar funds
Morgan Stanley's Q2 2015 Portfolio in Review
As of Q2 2015, Morgan Stanley held 7,065 positions worth $289B, up 6.3% from $272B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Morgan Stanley deployed $19B of net new capital in Q2 2015, opening 213 new positions and adding to 3,439 existing holdings. Its largest new stake was EQGP Holdings, LP: 2,862,984 shares worth $97.3M.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Trip.com Group, an estimated $546M trimmed.
- Morgan Stanley's largest Q2 2015 buy was EQGP Holdings, LP: 2,862,984 shares worth $97.3M.
- Morgan Stanley added most to Express Scripts Holding Company in Q2 2015, an estimated $2.7B increase.
- Morgan Stanley's biggest Q2 2015 reduction was Trip.com Group, cutting an estimated $546M.
- Morgan Stanley fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $162M.
- Morgan Stanley's ten largest holdings make up 12% of its $289B portfolio in Q2 2015.
- Morgan Stanley opened 213 new positions and closed 120 in Q2 2015.
- Morgan Stanley's portfolio value rose 6.3% quarter-over-quarter to $289B.
Based on Morgan Stanley's 13F filing for Q2 2015, filed 12 Aug 2015.